Model Information:

C1498 is an aggressive acute myeloid leukemia (AML) cell line which originated spontaneously in a C57BL/6 mouse. This model can be used to assess the efficacy and pharmacodynamics of the immune system following anti-cancer immunotherapy treatment. At CrownBio, the C1498 model is available both subcutaneously and systemically (via i.v. injection).

Summary

Cancer Type Leukemia
Subtype N/A
Mouse Strain C57BL/6
TMA TMA-CP-SY-008

Response to Immune Checkpoint Inhibitors

Additional Characteristics